HIV infection and lipids-Reference-Cited by-同舟云学术

HIV infection and lipids

Published:2018-07 Issue:4 Volume:33 Page:429-435
ISSN:0268-4705
Container-title:Current Opinion in Cardiology
language:en
Short-container-title:

Author:

Jain Anjly,Kolvekar Trupti,Nair Devaki R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference64 articles.

1. Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy;Trickey;PLoS One,2016

2. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome;Grunfeld;J Clin Endocrinol Metab,1992

3. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients;Calza;J Antimicrob Chemother,2004

4. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients;Fernandez-Montero;J Viral Hepat,2016

5. HIV/HCV coinfection and the risk of cardiovascular disease: a meta-analysis;Osibogun;J Viral Hepat,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalencia de glucosa alterada en ayuno y dislipidemia entre pacientes mexicanos con VIH <i>naïve</i> a tratamiento antirretroviral;Cirugía y Cirujanos;2023-02-22

2. Dyslipidemia Secondary to the Use of HAART in Adults: A Systematic Review;Current Drug Research Reviews;2022-11

3. Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China;Frontiers in Pharmacology;2021-03-25

4. Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status;iScience;2021-02

5. Distinct lipid profile, low-level inflammation and increased antioxidant defense as a signature in HIV-1 elite control status;2020-07-02